Varomedi
ActiveVaromedi has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €39k and a net result of €14k. Equity is shrinking by ~16.6% per year across the filed fiscal years. Its solvency ranks better than 24% of 16546 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
75
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability81▲+41
Solvency53▼-9
Growth32=
Track record100
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €2.5k at 30 days acceptable
Liquidity tight (current ratio 1.26 against 1.21 in 2024; short-term debt: 72.3% and cash: 48.3% of total assets), and 72.3% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
27.7%
Return on assets
9.8%
Age of the figures
9 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 24% of 16546 sector peers (2025).
NBB · sector comparisonPosition among 16546 sector peers
Solvency
better than 24%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 02-07-2026, 29 days ahead of the deadline.
NBB · 5 filingsDeviation from the deadline
2025
29 d early
2024
21 d early
2023
on the day
2022
40 d early
2021
30 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
23-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€39k▲ 55.1%
2024 · €25k
2021: €42k
2022: €74k
2023: €61k
2024: €25k
2021 → 2025
Total assets
€140k▲ 104%
2024 · €69k
2021: €68k
2022: €86k
2023: €72k
2024: €69k
2021 → 2025
Net result
€14k▲ 3,686%
2024 · €364
2021: €39k
2022: €34k
2023: €14k
2024: €364
2021 → 2025
Working capital
€27k▲ 187%
2024 · €9k
2021: €40k
2022: €61k
2023: €50k
2024: €9k
2021 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€42k-€74k▲ 77.6%€61k▼ 17.5%€25k▼ 59.2%€39k▲ 55.1%
Operating result€57k-€47k▼ 18.7%€24k▼ 48.0%€5k▼ 78.5%€26k▲ 392%
Net result€39k-€34k▼ 13.4%€14k▼ 57.8%€364▼ 97.5%€14k▲ 3,686%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 392% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €140k
Fixed assets
€12k▼ 23.6%
Current assets
€128k▲ 142%
Equity and liabilities €140k
Equity
€39k▲ 55.1%
Debt
€101k▲ 132%
The debt ratio rises from 63.5% to 72.3%. Equity and debt are higher.
Key figures and ratios
EBITDA
€29k▲
2024 · €9k
Cash flow
€18k▲
2024 · €4k
Solvency
27.7%▼
2024 · 36.5%
Current ratio
1.26▲
2024 · 1.21
Quick ratio
1.26▲
2024 · 1.21
Debt / equity
2.61▲
2024 · 1.74
ROE
35.5%▲
2024 · 1.5%
ROA
9.8%▲
2024 · 0.5%
Interest coverage
7.76▲
2024 · 2.48
Debt
€101k▲
2024 · €44k
Debt ≤ 1 year
€101k▲
2024 · €43k
Income taxes
€8k▲
2024 · €1k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€69k€140k▲
Fixed assets21/28€16k€12k▼
Tangible fixed assets22/27€16k€12k▼
Plant, machinery and equipment23€2k€913▼
Furniture and vehicles24€12k€9k▼
Other tangible fixed assets26€3k€2k▼
Current assets29/58€53k€128k▲
Amounts receivable within one year40/41€36k€57k▲
Trade receivables40€8k€57k▲
Other amounts receivable41€28k€0▼
Cash at bank and in hand54/58€17k€68k▲
Deferred charges and accrued income490/1€0€3k▲
Equity and liabilities
Total equity and liabilities10/49€69k€140k▲
Equity10/15€25k€39k▲
Contributions10/11€3k€3k=
Reserves13€23k€36k▲
Distributable reserves133€23k€36k▲
Profit (loss) carried forward14€0€0=
Amounts payable17/49€44k€101k▲
Amounts payable within one year42/48€43k€101k▲
Trade debts44€7k€87k▲
Suppliers440/4€7k€87k▲
Taxes, remuneration and social security45€6k€14k▲
Taxes450/3€6k€14k▲
Other amounts payable47/48€31k€731▼
Accrued charges and deferred income492/3€109€0▼
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€4k€4k▲
Other operating charges640/8€658€577▼
Gross operating margin9900€9k€30k▲
Operating profit (loss)9901€5k€26k▲
Financial income75/76B€12€0▼
Recurring financial income75€12€0▼
Financial charges65/66B€4k€4k▲
Recurring financial charges65€4k€4k▲
Profit (loss) for the period before taxes9903€2k€22k▲
Income taxes67/77€1k€8k▲
Profit (loss) for the period9904€364€14k▲
Profit (loss) for the period to be appropriated9905€364€14k▲
Appropriation of the result
Profit (loss) to be appropriated9906€364€14k▲
Transfer from equity791/2€36k€0▼
Transfer to equity691/2€0€14k▲
To other reserves6921€0€14k▲
Profit to be distributed694/7€37k€0▼
Return on contributions (dividend)694€37k€0▼
The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
02-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
10-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Weakest financial yearnet €364 ▼97.5%
Net result drops to €364, the lowest in the series; recovery starts the following year.
31-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
21-06
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial
Liquidity doublescurrent ratio 6.22
Current ratio from 2.84 to 6.22; short-term debt falls from €22k to €12k.
30-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 30 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Pelt · 1 establishment unit since 2020
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Kaemerveldstraat 163900 PeltGround area
557 m²
Building footprint
171 m²
Volume, LiDAR
1,149 m³
Parcel 72029B0244/00H000, Flanders · tallest building 10.7 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Varomedi
since 20202.307.314.848
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 72029B0244/00H000 | Flanders | 557 m² | 1 · 171 m² | 10.7 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
2CARE@HOME
BE 0558.884.306
Brugge · Eq €39k
INFI-KHAD
BE 0769.696.582
Sint-Jans-Molenbeek · Eq €39k
HHC SERVICES
BE 0797.492.725
Schaarbeek · Eq €39k
Thuisverpleging Jessica Goris
BE 0787.895.069
Aarschot · Eq €39k
Laurie PERAT
BE 0795.444.243
Hamois · Eq €39k
Of 5,983 companies in sector 86940 we hold annual accounts for 1,808. 1,574 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded09-09-2020
Fiscal year end31-12
Activities, NACEBEL
86906Human health activities
86940Nursing and midwifery
71209Other technical testing and analysis
72101Research and development on biotechnology
82100Office administrative and support services
82110Office administrative, office support and other business support activities
82990Other business support services
Sources
Crossroads Bank for EnterprisesNational Bank · 5 filingsAddress and cadastre registers
Data from official sources, last processed on 23-09-2026. Scores and ratios are computed by Checked and are not a credit decision.